HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

As FDA Decides CBD Regulatory Path, Sales March On For Suppliers, Retailers

Executive Summary

CV Sciences distributes PlusCBD Oil products to Vitamin Shoppe stores in 30 states and Puerto Rico, pushing its US distribution to more than 5,300 retail locations. Vitamin Shoppe began offering CBD products in March and has extended the sales to 390 stores.

You may also be interested in...



CBD Anti-inflammatory Benefits: For Copeland Biosciences, That's The Rub

Toronto firm is making CBD topicals physicians use with patients and it's s ready to market products OTC as soon as it has Canada's stamp of approval. It's waiting for US regulatory landscape to settle before crossing the border. Company also has research help from Marc Feldmann, immunologist whose work led to most-used therapy for rheumatoid arthritis, other autoimmune diseases.

Canada Is Large Firms' CBD Test Market While US Weighs Allowing Sales

Large beer and beverage firms partner with hemp cultivators to compete in fledgling US CBD-infused beverage market, which is estimated to reach $1.4bn sales by 2023. Many firms are working on R&D or have completed products and are waiting for a clear regulatory pathway from FDA before launch.

Vitamin Shoppe's Buyer Took Tumultuous Path Toward Recent Turn To Investing

Liberty Tax, which owns tax-return preparation business Liberty Tax Services and branched into capital investing in July, agrees to pay $6.50 per Vitamin Shoppe share, a 43% premium on its closing price a day earlier. Vitamin Shoppe's earnings struggles continued in Q2 as total sales fell 7.6% to $270.9m and it reported a $3.6m net loss after generating $5.3m net income a year ago.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL1134043

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel